BLAZE-1 Final Publication: Monoclonal Antibody Cocktail Part II
Background: One of the many massive challenges of the COVID19 pandemic has been the lack of targeted therapeutics. Extensive efforts have been invested into research with only glimmers of benefit for most drugs. The exception to this has been dexamethasone ...